THIOTEPA — all Canadian products
10 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is THIOTEPA, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02462702 | TEPADINA | ADIENNE SA | Powder For Solution | Intravenous | THIOTEPA 100 MG | Marketed | |
| 02567059 | TEPADINA | ADIENNE SA | Powder For Solution | Intravenous | THIOTEPA 200 MG | Approved | |
| 02462680 | TEPADINA | ADIENNE SA | Powder For Solution | Intravenous | THIOTEPA 15 MG | Marketed | |
| 02526417 | THIOTEPA FOR INJECTION USP | STERIMAX INC | Powder For Solution | Intravenous | THIOTEPA 15 MG | Marketed | |
| 02526425 | THIOTEPA FOR INJECTION USP | STERIMAX INC | Powder For Solution | Intravenous | THIOTEPA 100 MG | Marketed | |
| 02536862 | THIOTEPA FOR INJECTION, BP | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | THIOTEPA 15 MG | Marketed | |
| 02536870 | THIOTEPA FOR INJECTION, BP | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | THIOTEPA 100 MG | Marketed | |
| 02523906 | TEPADINA | ADIENNE SA | Powder For Solution | Intravenous | THIOTEPA 400 MG | Dormant | |
| 00237035 | THIO TEPA INJ 15MG/VIAL | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Oral; Vaginal; Rectal; Surgical | THIOTEPA 15 MG | Cancelled Post Market | |
| 02174391 | THIOTEPA - (PWS 15 MG/VIAL) | WYETH CANADA | Powder For Solution | Intracavitary; Intravesicular; Intravenous | THIOTEPA 15 MG | Cancelled Post Market |
Browse other molecules: